Aviso Financial’s Boston Scientific BSX Stock Holding History

Aviso Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$844K	Sell	19,335 -892	-4%	-$41.3K	0.03%	133
2026 Q2	$863K	Sell	20,227 -941	-4%	-$51.1K	0.03%	138
2026 Q1	$1.33M	Buy	21,168 +6,490	+44%	+$519K	0.05%	135
2025 Q4	$1.4M	Buy	14,678 +529	+4%	+$51.9K	0.05%	128
2025 Q3	$1.38M	Sell	14,149 -752	-5%	-$77.9K	0.06%	137
2025 Q2	$1.6M	Sell	14,901 -1,540	-9%	-$156K	0.07%	115
2025 Q1	$1.66M	Sell	16,441 -606	-4%	-$61K	0.08%	109
2024 Q4	$1.52M	Sell	17,047 -6,093	-26%	-$536K	0.08%	113
2024 Q3	$1.94M	Sell	23,140 -1,014	-4%	-$79.9K	0.1%	98
2024 Q2	$1.86M	Buy	+24,154	New	+$1.77M	0.1%	91

Other funds holding BSX

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return

Aviso Financial's BSX Position: Q3 2026 in Review

Aviso Financial reduced its Boston Scientific (BSX) stake by 4.4% in Q3 2026, selling an estimated $41.3K and leaving 19,335 shares worth $844K. The position accounts for 0.03% of the portfolio, ranked #133.

Aviso Financial first reported a position in BSX in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.94M in Q3 2024. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Aviso Financial held 19,335 shares of Boston Scientific worth $844K as of Q3 2026.
Aviso Financial sold 892 Boston Scientific shares in Q3 2026, an estimated $41.3K.
Boston Scientific made up 0.03% of Aviso Financial's portfolio in Q3 2026, its #133 holding.
Aviso Financial first reported a position in Boston Scientific in Q2 2024 and has held it in 10 quarters since.
Aviso Financial's Boston Scientific position peaked at $1.94M in Q3 2024.
1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Aviso Financial's 13F filing for Q3 2026, filed 12 Nov 2026.